Pharmacies
Gaps in Medicare Advantage Data Remain Despite CMS Actions to Increase Transparency
[ad_1] The Centers for Medicare and Medicaid Services (CMS) has recently taken actions to increase transparency…
Blog
Pharmacies
Prescription Medication
Long COVID Rates Appear to be Stabilizing, Affecting About 1 in 10 Adults Who Have Had COVID
[ad_1] Rates of long COVID have begun to flatten. About 1 in 10 adults with COVID…
Drug Prices
Upcoming SCOTUS Case Could Weaken the Impact of Regulation on Key Patient and Consumer Protections
[ad_1] The U.S. Supreme Court is considering jointly two cases, Loper Bright Enterprises v. Raimondo and Relentless, Inc….
Prescription Medication
As Recommendations for Isolation End, How Common is Long COVID?
[ad_1] In March 2024, the Centers for Disease Control and Prevention (CDC) updated its recommendations for…
Pharmacies
Experience of the Five Largest Publicly Traded Companies Operating Medicaid Managed Care Plans During Unwinding
[ad_1] At the start of the “unwinding” period, in April 2023, Medicaid enrollment peaked at 94.5…
Pharmacies
Variability in Payment Rates for Abortion Services Under Medicaid
[ad_1] Key Takeaways There is tremendous variability in how much states reimburse for abortion services in…
Pharmacies
SUD Treatment in Medicaid: Variation by Service Type, Demographics, States and Spending
[ad_1] Substance use disorders (SUDs), including opioid and alcohol use disorders (OUDs and AUDs), are a…
Prescription Medication
PEPFAR’s Short-Term Reauthorization Sets an Uncertain Course for Its Long-Term Future
[ad_1] After months of partisan negotiations and wrangling over the federal budget, Congress finally agreed to…
Health
Gross Medicare Spending on Ozempic and Other GLP-1s Is Already Skyrocketing – Even Though Medicare Cannot Cover The Drugs for Weight Loss
[ad_1] A KFF analysis shows that gross total Medicare spending on Ozempic and other similar drugs…
Health
Medicare Spending on Ozempic and Other GLP-1s Is Skyrocketing
[ad_1] GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro were initially developed to treat type 2…